EST Olema Oncology (OLMA) files $200M mixed securities shelfDon't Miss Our New Year's Offers:Discover the latest stocks recommended by ...

The company is not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale by the selling ...

Olema Pharmaceuticals, Inc. (“Olema” or “”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast ...

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...

Olema Pharmaceuticals Inc (OLMA) stock saw a modest uptick, ending the day at $5.83 which represents a slight increase of $0.22 or 3.92% from the prior close of $5.61. The stock opened at $5.61 and ...

Geode Capital Management LLC reduced its stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 11.8% ...

Novartis NVS announced positive top-line results from the late-stage STEER study on experimental candidate intrathecal ...

A Pulitzer Prize-winning weekly covering West Marin, including the towns of Point Reyes Station, Inverness, Bolinas, Stinson ...

A Pulitzer Prize-winning weekly covering West Marin, including the towns of Point Reyes Station, Inverness, Bolinas, Stinson ...

State Street Corp increased its holdings in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 1.1% in the third quarter, according to the company in its most recent filing with the ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...